Your browser doesn't support javascript.
loading
Clinical-epidemiological profile of deaths from influenza with a history of timely vaccination, Mexico 2010-2018
Kuri-Morales, Pablo Antonio; Díaz del Castillo-Flores, Guadalupe; Castañeda-Prado, Andrés; Pacheco-Montes, Salma Rosario.
  • Kuri-Morales, Pablo Antonio; Universidad Nacional Autónoma de México. Faculty of Medicine. Ciudad de México. MX
  • Díaz del Castillo-Flores, Guadalupe; Sub-directorate of Prevention and Control of Diseases. Servicios de Salud de Veracruz. Veracruz. MX
  • Castañeda-Prado, Andrés; Universidad Nacional Autónoma de México. Faculty of Medicine. Ciudad de México. MX
  • Pacheco-Montes, Salma Rosario; Secretaría de Salud. General Directorate of Epidemiology. Mexico City. MX
Gac. méd. Méx ; 155(5): 423-429, Sep.-Oct. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1286538
ABSTRACT

Introduction:

Influenza epidemics are of higher risk at the extremes of life and in people with comorbidities. Effective vaccination prevents the occurrence of serious cases and decreases mortality.

Objective:

To describe deaths from influenza with a history of timely vaccination, from the 2010 to the 2018 season in Mexico.

Method:

Cross-sectional, descriptive study where the Influenza Epidemiological Surveillance System database was used.

Results:

From 2010 to 2018, 65 vaccinated individuals died from influenza, from which 55% of cases (n = 36) were due to type A (H1N1), 51% (n = 33) were females, median age was 57 years, 21 % (n = 14) did not meet the operational definition of influenza-like illness or severe acute respiratory infection, 83% (n = 54) had at least one comorbidity, with the most common being diabetes mellitus and hypertension (32% each); 55% (n = 36) of deaths received antiviral treatment and only 8% (n = 5) had no comorbidities and received treatment with oseltamivir.

Conclusions:

Deaths from influenza with timely vaccination represent a very low percentage of the totality. Vaccination against influenza has been a specific prevention strategy that decreases disease burden.
Asunto(s)


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Vacunas contra la Influenza / Inmunización / Gripe Humana Tipo de estudio: Estudio observacional / Estudio de prevalencia / Factores de riesgo / Estudio de tamizaje Límite: Femenino / Humanos / Masculino País/Región como asunto: México Idioma: Inglés Revista: Gac. méd. Méx Asunto de la revista: Medicina Año: 2019 Tipo del documento: Artículo País de afiliación: México Institución/País de afiliación: Secretaría de Salud/MX / Sub-directorate of Prevention and Control of Diseases/MX / Universidad Nacional Autónoma de México/MX

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Vacunas contra la Influenza / Inmunización / Gripe Humana Tipo de estudio: Estudio observacional / Estudio de prevalencia / Factores de riesgo / Estudio de tamizaje Límite: Femenino / Humanos / Masculino País/Región como asunto: México Idioma: Inglés Revista: Gac. méd. Méx Asunto de la revista: Medicina Año: 2019 Tipo del documento: Artículo País de afiliación: México Institución/País de afiliación: Secretaría de Salud/MX / Sub-directorate of Prevention and Control of Diseases/MX / Universidad Nacional Autónoma de México/MX